• English
  • English
Transpara
  • Homepage
  • About us
    • History
    • Technology
    • Our Team
    • Coverage
    • Join us
  • The Experience
  • Transpara
    • Fusion AI
    • Exam Score
    • Transpara Findings
    • Radiologists
    • Healthcare Providers
    • Women
  • News and Evidence
    • News
    • Evidence
      • Peer Reviewed Publications
      • International Scientific abstracts and presentations
    • Resources
  • Join Us
Transpara

Announcement


The latest AI breast cancer identification system, Transpara™ 1.6 will be showcased at RSNA 2019

1st December 2019

The latest AI breast cancer identification system, Transpara™ 1.6 will be showcased at RSNA 2019

The most advanced version of Transpara™ from ScreenPoint Medical unleashes the power from 2D into 3D mammography: Performance is better, faster and even more accurate.

Transpara™ 1.6, the leading Artificial Intelligence decision support system for breast cancer screening, that uses deep learning algorithms to automatically detect potential breast cancer in 2D and 3D DBT mammograms, will be unveiled at the Annual Radiological Society of North America (RSNA) meeting, December 1-6, 2019 (ScreenPoint Medical, South Hall #4380).

Read the full release

 

Post navigation

Previous story
Next story

Book a demo today

Discover how Transpara can help you

Contact us
Screen Point

© 2022, ScreenPoint Medical BV.  All rights reserved.  Transpara® is a registered trademark of ScreenPoint Medical BV.  Reproduction of any material contained herein in any format or media without express written permission of ScreenPoint Medical BV is prohibited. *Disclaimer:  Transpara is CE marked and FDA cleared for 2D and 3D mammography.  CE (0344) certified. FDA 510(k) K210404.  Not all features are available in all countries.  Please check with local representatives.

  • News and Resources
  • Clinical Studies
  • Radiologists
  • Healthcare Providers
  • Women
  • Contact us
  • Security Reporting
  • Privacy Policy
  • Cookie Policy

Office: +31 242 020 020

US: 1-833-MammoAI (626-6624)

info@screenpointmed.com

Technical support: +31 242 020 028

support@screenpointmed.com

LinkedIn Twitter